PES5 COST-UTILITY ANALYSIS OF TIMOLOL VERSUS LATANOPROST VERSUS TRAVOPROST IN THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61457-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61457-X/fulltext
Title :
PES5 COST-UTILITY ANALYSIS OF TIMOLOL VERSUS LATANOPROST VERSUS TRAVOPROST IN THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61457-X&doi=10.1016/S1098-3015(10)61457-X
First page :
Section Title :
Open access? :
No
Section Order :
265